id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0525-0012,FDA,FDA-2008-D-0525,Guidance for Industry on New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products; Availability,Notice,NAD-Notice of Availability of Data,2010-01-06T05:00:00Z,2010,1,2010-01-06T05:00:00Z,,2010-01-06T12:59:25Z,E9-31307,0,0,0900006480a77902